We are live on
!
Find out more
RP
Regeneron Pharmaceuticals Portfolio holdings
AUM
$47.9M
1-Year Est. Return
29.29%
This Fund
S&P 500
This Quarter
Est. Return
-15.69%
1 Year Est. Return
+29.29%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.09B
AUM Growth
–
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
112.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$1.17B |
| 2 |
Intellia Therapeutics
NTLA
|
+$57.8M |
| 3 |
TSVT
2seventy bio
TSVT
|
+$5.15M |
| 4 |
ADVM
Adverum Biotechnologies
ADVM
|
+$1.22M |
| 5 |
Adicet Bio
ACET
|
+$1.14M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$38.5B
| $1.05B | 95.54% |
+4,444,445
| New | +$1.17B |
|
|
2
Intellia Therapeutics
NTLA
$1.82B
| $43.2M | 3.94% |
+3,702,995
| New | +$57.8M |
|
|
TSVT
3
DELISTED
2seventy bio
TSVT
| $3.69M | 0.34% |
+1,254,827
| New | +$5.15M |
|
|
4
Adicet Bio
ACET
$79.9M
| $931K | 0.09% |
+60,511
| New | +$1.14M |
|
|
ADVM
5
DELISTED
Adverum Biotechnologies
ADVM
| $845K | 0.08% |
+180,909
| New | +$1.22M |
|
|
BLUE
6
DELISTED
bluebird bio
BLUE
| $175K | 0.02% |
+21,000
| New | +$184K |
|
Similar funds
PFA
CCG
IPHI
FWM
EGI
CT
PEP
FCM